Early Detection of Vulval CAncer Through Self-Examination (EDuCATE): Intervention Study
1 other identifier
interventional
25
1 country
1
Brief Summary
Vulval cancer, while rare, has increased in incidence by 17% since the 1990s. It is strongly associated with age, thus this increasing trend is likely to continue with extended life expectancy. Vulval cancer is highly treatable when detected early. Women with chronic vulval conditions including lichen sclerosus, lichen planus and vulval intraepithelial neoplasia are at increased risk of developing vulval cancer. Most patients are in hospital follow-up, however regular vulval self-examination can pick up lesions earlier. There are no formalised methods of teaching self-examination and no evidence that it is acceptable to women. The main objective of this study is to pilot an intervention to promote and support vulval self-examination for women at increased risk of vulval cancer including those with lichen sclerosus, lichen planus and vulval intraepithelial neoplasia. Findings from this feasibility study will inform the design of a randomised trial comparing the interventions versus control with an embedded cost-effectiveness analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
July 7, 2021
CompletedStudy Start
First participant enrolled
November 4, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
March 6, 2023
CompletedJune 22, 2023
June 1, 2023
9 months
June 16, 2021
June 16, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Change in number of self-reported vulval self-examination events
Change in number of self-reported vulval self-examination events over one month before and after the intervention. Patients are asked to record self-examination events in the patient diary
6 months
Secondary Outcomes (4)
Change in Perceived Vulval Cancer Risk Score
6 months
Change in Vulval Cancer Worry Scale
6 months
Change in the Hospital anxiety and depression scale
6 months
Vulval quality of life index
6 months
Study Arms (1)
Single Arm Intervention
EXPERIMENTALParticipants will be shown how to perform vulval self-examination in a face-to-face intervention and provided with an information leaflet. They will be sent reminders to self-examine each month.
Interventions
Face-to-face training in vulval self-examination Supplemented with use of aids ( hand mirror, mobile phone with selfie-stick), patient information leaflet, reminders to self-examine
Eligibility Criteria
You may qualify if:
- Prior diagnosis of a vulval condition with increased risk of malignancy ( lichen sclerosus, lichen planus or vulval intraepithelial neoplasia)
- New diagnosis of a vulval condition with increased risk of malignancy ( lichen sclerosus, lichen planus or vulval intraepithelial neoplasia)
- Must be able to provide informed consent
You may not qualify if:
- Inability to consent or complete questionnaires due to cognitive or language issues
- Inability of perform a vulval self-examination due to physical or visual impairments
- Note: Those with physical or visual impairments can participate if a dyad is willing to learn how to perform a vulval examination
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
St Mary's Hospital, Manchester University Hospitals Foundation Trust
Manchester, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Vanitha Sivalingam, PhD
University of Manchester
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Academic Clinical Lecturer in Gynaecological Oncology
Study Record Dates
First Submitted
June 16, 2021
First Posted
July 7, 2021
Study Start
November 4, 2021
Primary Completion
July 30, 2022
Study Completion
March 6, 2023
Last Updated
June 22, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share